Dave Abroamowitz of Thermo Fisher Cientific concludes his five-part video series with thoughts on how laboratories can address potential biases or errors introduced by artificial intelligence (AI) ...

Researchers studying tear-lipid fingerprints associated with aqueous-deficient dry eye (ADDE) and Meibomian-gland dysfunction ...

Artificial intelligence (AI) will of course revolutionize method development, peak detection, and data interpretation as it becomes more widely applied and accepted. We asked Dave Abramowitz of Thermo ...

Research regarding the connection between sodium intake and cadiometabolic risk used ultrahigh performance liquid ...

The September issue of LCGC International delivers new perspectives in oligonucleotide analysis, robust data statistics, and advanced workflows for complex biologics.

High-quality, well-labeled data is essential. What steps are being taken—or should be taken—to create standardized, shared chromatographic datasets for AI training? Dave Abramowitz of Thermo Fisher ...

Australian researchers set out to determine the chemical composition of anabolic–androgenic steroid (AAS) sold there, ...

What role will human expertise have when artificial intelligence (AI) becomes more deeply embedded in chromatography workflows? Dave Abramowitz of Thermo Fisher Scientific shares his thoughts.

Researchers aiming to investigate the value of serum vitamin D3 levels in patients with a history of malignancy and confirmed ...

Dave Abramowitz of Thermo Fisher Scientific on how he sees artificial intelligence (AI)-driven chromatography tools scaling from research labs to regulated pharmaceutical environments, where ...

LCGC International spoke to Dave Abramowitz, unified product management and product ownership team for chromatography and ...

In this episode of Analytically Speaking, explore the intersection of forensic science and cannabis research with Brent ...